MRI影像生物标志物在肝细胞癌诊疗中的应用
本文综述MRI影像特征反映肝细胞癌生物学行为及预后的研究进展。增殖型HCC具有侵袭性行为、微血管侵犯和不良预后,可通过动脉期环形强化、非光滑边缘、坏死等特征识别。影像特征可辅助选择性活检、分子分型和治疗决策。
要点
- 动脉期环形强化、非光滑边缘提示增殖型HCC,预后较差
- 包膜、瘤内脂肪、HBP高信号提示肿瘤生物学行为较惰性
- 影像特征可疑侵袭性亚型时,可建议组织学确认以指导治疗
核心结论
- MRI影像特征可反映HCC肿瘤生物学行为,为预后评估和临床决策提供诊断之外的增量信息
研究设计与样本
- 本文为叙述性综述,系统回顾MRI影像特征与HCC分子分型、微血管侵犯及预后相关性的研究证据
关键影像表现/征象
- 动脉期环形强化(rim APHE)、非光滑边缘、坏死、瘤内动脉与侵袭性行为和不良预后相关
- 低表观扩散系数(low ADC)、瘤周动脉期强化、瘤周肝胆期低信号提示侵袭性肿瘤生物学特征
- 包膜显示、瘤内脂肪、肝胆期高信号与较有利的肿瘤生物学行为相关
诊断标准与关键数值
- MRI可区分增殖型HCC与非增殖型HCC,前者以侵袭性行为、常见微血管侵犯和不良预后为特征
- 影像组学和人工智能分析可增强微血管侵犯预测、复发风险分层和非侵入性分子特征识别能力
临床应用与阅片要点
- 阅片时重点关注动脉期环形强化、边缘形态、坏死、ADC值及瘤周肝胆期信号等侵袭性征象
- 当影像特征提示侵袭性亚型时,可建议组织学确认,以进行分子分型或指导治疗规划
局限性
- HCC分子和组织病理因素通常因非侵入性诊断而无法获取,未能纳入当前分期系统
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatocellular carcinoma (HCC) is a biologically heterogeneous malignancy staged according to tumor burden and clinical status. Molecular and histopathologic factors remain unincorporated into current staging systems, as they are usually unavailable because HCC is often diagnosed noninvasively. Emerging evidence indicates that magnetic resonance imaging (MRI) features reflect underlying tumor biology and provide prognostic information beyond diagnosis. MRI can differentiate proliferative-class HCC, which is characterized by aggressive behavior, frequent microvascular invasion (MVI), and poor outcomes, from non-proliferative-class HCC with more favorable biology. Several MRI features, including rim arterial phase hyperenhancement (APHE), non-smooth margins, necrosis, intratumoral arteries, low apparent diffusion coefficient, peritumoral APHE, and peritumoral hepatobiliary phase (HBP) hypointensity, have been associated with aggressive tumor behavior and adverse outcomes. In contrast, capsule appearance, intratumoral fat, and HBP hyperintensity are associated with more favorable biology. Although biopsy is not routinely required when characteristic imaging features of HCC are present, imaging features suggestive of aggressive tumor subtypes may identify patients who could benefit from histologic confirmation for diagnostic clarification, molecular profiling, or treatment planning. Radiomics and artificial intelligence-based analyses further enhance MVI prediction, recurrence risk stratification, and noninvasive molecular characterization. In conclusion, the emerging role of MRI in characterizing tumor biology underscores the growing importance of imaging biomarkers in clinical decision-making and selective biopsy strategies.
引用
- Yoon, Choi. Beyond Diagnosis: Magnetic Resonance Imaging-Based Imaging Biomarkers for Tumor Biology, Prognosis, and Clinical Decision-Making in Hepatocellular Carcinoma. Korean J Radiol. 2026. PMID: 42551870. doi:10.3348/kjr.2026.0320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。